Technical Analysis for SEOVF - Sernova Corp

Grade Last Price % Change Price Change
grade D 0.1365 -4.48% -0.0064
SEOVF closed down 4.48 percent on Friday, December 13, 2019, on 84 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
See historical SEOVF trend table...

Date Alert Name Type % Chg
MACD Bearish Signal Line Cross Bearish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
BB Squeeze + Lower Band Touch Range Contraction 0.00%
Below Lower BB Weakness 0.00%
Gapped Down Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Bollinger Band Squeeze Range Contraction -4.48%
Narrow Range Bar Range Contraction -4.48%
Gapped Down Weakness -4.48%
Older signals for SEOVF ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


Sernova Corp. is a clinical stage regenerative medicine company developing cell therapy based medical technologies for the treatment of chronic debilitating diseases such as diabetes, blood disorders including hemophilia and other diseases all of which are treated through replacement of proteins or hormones missing or in short supply within the body. Sernova is developing the Cell Pouch(TM), a scalable, implantable medical device which forms a vascularized organ-like environment for the transplantation of its locally immune-protected therapeutic cells (self-cells, donor cells, ethically sourced stem cell derived therapeutic cells or xenogeneic cells) which then release proteins and/or hormones as required by the body. The objective of the company's products is to disrupt the standard of care treatments for these serious diseases to improve efficacy, significantly improve patient quality of life and to decrease the severe debilitating disease effects that progress with the standard of care treatments. The product to treat diabetes involves implantation of a small biocompatible medical device under the skin into which are placed immune protected cells which connect to the blood vessel supply to read blood sugar levels and release insulin accordingly, replacing the metabolic function of the pancreas. For hemophelia the cells would release the required protein, Factor VIII on a constant basis reducing or eliminating the need for frequent infusions of Factor VIII.
Biotechnology Branches Of Biology Biology Diabetes Diseases Cell Therapy Regenerative Medicine Cell Biology Transplantation Blood Cloning Hemophilia Developmental Biology Serious Diseases Stem Cell Blood Disorders Cell Encapsulation Diabetes Mellitus Type 1

Is SEOVF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News


Indicator Value
52 Week High 0.2464
52 Week Low 0.1089
Average Volume 33,958
200-Day Moving Average 0.1561
50-Day Moving Average 0.1633
20-Day Moving Average 0.1484
10-Day Moving Average 0.1487
Average True Range 0.0080
ADX 22.47
+DI 19.0603
-DI 37.4113
Chandelier Exit (Long, 3 ATRs ) 0.1389
Chandelier Exit (Short, 3 ATRs ) 0.1605
Upper Bollinger Band 0.1588
Lower Bollinger Band 0.1380
Percent B (%b) -0.07
BandWidth 14.0162
MACD Line -0.0040
MACD Signal Line -0.0036
MACD Histogram -0.0004
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.1415
Resistance 3 (R3) 0.1420 0.1409 0.1406
Resistance 2 (R2) 0.1409 0.1396 0.1406 0.1403
Resistance 1 (R1) 0.1387 0.1389 0.1382 0.1382 0.1401
Pivot Point 0.1376 0.1376 0.1373 0.1373 0.1376
Support 1 (S1) 0.1354 0.1363 0.1349 0.1349 0.1329
Support 2 (S2) 0.1343 0.1356 0.1340 0.1327
Support 3 (S3) 0.1321 0.1343 0.1324
Support 4 (S4) 0.1316